Todas las fotos(1)

Documentos clave

Certificado de origen (COO)/COA

SAB3700759

Anti-Monkey IgA (α-chain specific)-Peroxidase antibody produced in goat

Name: Anti-Monkey IgA (α-chain specific)-Peroxidase antibody produced in goat
Brand: SIGMA

affinity isolated antibody, lyophilized powder

Sinónimos:

HRP

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización

Todas las fotos(1)

About This Item

Código UNSPSC:

12352203

NACRES:

NA.46

origen biológico

goat

conjugado

peroxidase conjugate

forma del anticuerpo

affinity isolated antibody

tipo de anticuerpo

secondary antibodies

clon

polyclonal

Formulario

lyophilized powder

reactividad de especies

monkey

técnicas

immunohistochemistry: suitable
indirect ELISA: suitable
western blot: suitable

Condiciones de envío

wet ice

temp. de almacenamiento

2-8°C

Especificidad

This product was prepared from monospecific antiserum by immunoaffinity chromatography using Monkey IgA coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. Assay by immunoelectrophoresis resulted in a single precipitin arc against Anti-Peroxidase, Anti-Goat Serum, Monkey IgA and Monkey Serum. No reaction was observed against Monkey IgM or Monkey IgG.

Inmunógeno

Monkey IgA alpha heavy chain

Propiedades físicas

Antibody format: IgG

Forma física

Supplied in 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 10 mg/mL Bovine Serum Albumin (BSA) - Immunoglobulin and Protease free

Reconstitución

Reconstitute with 1.0 mL deionized water (or equivalent).

Cláusula de descargo de responsabilidad

For U.S. Customers: Contains mercury; Do not place in trash - dispose according to local, state, or federal laws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?

Pruebe nuestro Herramienta de selección de productos.

Pictogramas

GHS06,GHS08,GHS09

Palabra de señalización

Danger

Frases de peligro

H301,H310,H332,H373,H411

Consejos de prudencia

P262 - P273 - P280 - P301 + P310 - P302 + P352 + P310 - P304 + P340 + P312

Clasificaciones de peligro

Acute Tox. 2 Dermal - Acute Tox. 3 Oral - Acute Tox. 4 Inhalation - Aquatic Chronic 2 - STOT RE 2

Órganos de actuación

Kidney

Código de clase de almacenamiento

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.

Eirikur Saeland et al.

NPJ vaccines, 8(1), 45-45 (2023-03-24)

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously shown that a prefusion (preF) conformation-stabilized RSV F protein antigen and an adenoviral vector encoding RSV preF protein

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.

Ahmed O Hassan et al.

Cell reports. Medicine, 2(4), 100230-100230 (2021-03-24)

The deployment of a vaccine that limits transmission and disease likely will be required to end the coronavirus disease 2019 (COVID-19) pandemic. We recently described the protective activity of an intranasally administered chimpanzee adenovirus-vectored vaccine encoding a pre-fusion stabilized spike

Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization.

A L Carvalho et al.

Clinical and experimental immunology, 196(3), 287-304 (2019-04-16)

Plague caused by the Gram-negative bacterium, Yersinia pestis, is still endemic in parts of the world today. Protection against pneumonic plague is essential to prevent the development and spread of epidemics. Despite this, there are currently no licensed plague vaccines

Systemic inflammation, innate immunity and pathogenesis after Zika virus infection in cynomolgus macaques are modulated by strain-specificity within the Asian lineage.

Ruklanthi de Alwis et al.

Emerging microbes & infections, 10(1), 1457-1470 (2021-06-15)

Zika virus (ZIKV) is an emerging arbovirus with recent global expansion. Historically, ZIKV infections with Asian lineages have been associated with mild disease such as rash and fever. However, recent Asian sub-lineages have caused outbreaks in the South Pacific and

Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations.

N C Salisch et al.

NPJ vaccines, 4, 54-54 (2019-12-31)

Respiratory Syncytial Virus (RSV) can cause severe respiratory disease, yet a licensed vaccine is not available. We determined the immunogenicity of two homologous and one heterologous intramuscular prime-boost vaccination regimens using replication-incompetent adenoviral vectors of human serotype 26 and 35

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico